Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04971889 · ClinicalTrials.gov registry record · NA

Diabetes Medical Nutrition Therapy in Southeastern African American Women

A NA study of Type 2 Diabetes, sponsored by Meharry Medical College.

Active
Registry status
NA
Development phase
291
Enrollment target
2
Study locations

NCT04971889: Active NA study of Type 2 Diabetes, sponsored by Meharry Medical College.

NCT04971889 is a NA study of Type 2 Diabetes that is active but no longer recruiting, run by Meharry Medical College. The registered enrollment target is 291 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04971889, a NA study of Type 2 Diabetes, is active but no longer recruiting, sponsored by Meharry Medical College.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
291 participants
Enrollment target
2
Study locations

Study Summary

A two-arm randomized controlled trial design will be used. Participants will include 291 African American women with type 2 diabetes that are at risk for development and/or progression of diabetes complications. Both arms, diabetes medical nutrition therapy (MNT) and diabetes MNT plus motivational interviewing (MI), will include: 1) a 3-month active intervention period of six biweekly (every other week), group-based, trained nutritionist-facilitated sessions; 2) a 3-month maintenance intervention period, which will include one group-based maintenance support session; and 3) a 6-month inactive period (no contact). The differences between arms is the integration of culturally-adapted MI exercises during the diabetes MNT plus MI active and maintenance intervention periods.

Primary Outcome

Widely-utilized high performance liquid chromatography methods will be used to measure glycemic control from whole blood samples.

Conditions Studied

Interventions

  • BEHAVIORAL Motivational Interviewing
  • BEHAVIORAL Diabetes MNT

Study Locations (2)

Tennessee

  • Matthew Walker Comprehensive Health Center - Nashville
  • Meharry Medical College - Nashville

Trial Details

FieldValue
Enrollment Target 291 participants
Start Date 2021-08-03
Est. Completion 2026-01-31
Phase NA
Meharry Medical College

10 total trials

What the registry record for NCT04971889 still lists

NCT04971889 is an interventional study that assigns participants to a tested intervention. The registered 291 participants enrollment target is mid-sized for trials with a published cap, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Motivational Interviewing is the first listed.

NCT04971889 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT04971889 about?

NCT04971889 is a clinical study titled "Diabetes Medical Nutrition Therapy in Southeastern African American Women". A two-arm randomized controlled trial design will be used. Participants will include 291 African American women with type 2 diabetes that are at risk for development and/or progression of diabetes complications. Both arms, diabetes medical nutrition therapy (MNT) and diabetes MNT plus motivational i...

What is the current status of trial NCT04971889?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 291 participants. The study started on 2021-08-03. Estimated completion is 2026-01-31.

What conditions does trial NCT04971889 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT04971889?

The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Diabetes MNT (BEHAVIORAL).

Who is sponsoring clinical trial NCT04971889?

This trial is sponsored by Meharry Medical College, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04971889 being conducted?

This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04971889's enrollment target sits among peer trials

291 73rd of 327 higher than 255 of 327 other Type 2 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02074839 · 291 participants · Phase 1

    Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

  • NCT03769766 · 291 participants · Phase 3

    Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

  • NCT06563479 · 291 participants · Phase 3

    A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

  • NCT04429542 · 292 participants · Phase 1

    Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04971889, the US trial registry maintained by the National Library of Medicine. NCT04971889 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.